中文摘要

随着知识大爆炸时代的到来，全球范围的竞争角逐愈加激烈，同时企业的高管人力资本成了普遍的稀缺资源，所以企业在对市场进行激烈的竞争同时，对领导人才的竞争也更加残酷。而高级管理者作为企业的主要领导者，掌握着公司未来发展的命运，好的管理者能够带领企业取得更好的效益。近几年来，中国医药企业综合竞争力的明显提升，中国医药产业正以高速度占有国内生产总值更大比重。就像在最近的金融风暴中，医药产业面对危机所展现的稳定性证实了这个产业不同于其他的显著特征和对经济稳定发展的有机保障。如何应对企业人才流失，留住并最大化激发他们的管理能力为本企业服务，是整个医药行业乃至中国所有企业迫切期望解决的问题。基于以上原因分析，医药高管薪酬激励对企业绩效的研究更具有现实价值。

关键词：上市公司高管薪酬公司绩效

Abstract

With the advent of knowledge explosion, global competition is becoming increasingly fierce competition, and enterprise executives human capital into widespread scarce resources, so enterprises in market competition of the same time, to leadership talents competition also more cruel. But senior managers as enterprise’s main leader, hold the fate of the company’s future development, good managers Able to lead the enterprise to obtain better benefit. In recent years, Chinese medicine enterprise comprehensive competitiveness of Chinese medicine industry increased, with high speed is occupies GDP bigger proportion. Just like in the recent financial storm, medicine industry facing crisis shows stability confirmed that the industry is different from other remarkable features and on economic stable development of organic safeguard. How to cope with the loss of talented people, retaining and enterprises maximize inspire their management ability for this enterprise service, is the whole medical industry and China all enterprise urgent expected to resolve problems. Based on the above reason analysis, pharmaceutical executives of enterprise performance salary incentive has more practical value of the research.

Keywords: The listed company Executive pay Company performance